Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial

Cystic fibrosis (CF) is a progressive, multi-system disease that primarily affects the respiratory system [1]. Despite significant improvement in the care of patients with CF and in life expectancy, approximately 20% of patients continue to develop severe lung disease by the age of 30 [2].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: Original Article Source Type: research